Literature DB >> 21799244

The impact of mitochondrial and nuclear DNA variants on late-onset Alzheimer's disease risk.

Aleksandra Maruszak1, Krzysztof Safranow, Wojciech Branicki, Katarzyna Gawęda-Walerych, Ewelina Pośpiech, Tomasz Gabryelewicz, Jeffrey A Canter, Maria Barcikowska, Cezary Zekanowski.   

Abstract

We investigated the potential contribution of mitochondrial DNA (mtDNA) variants, haplogroups, and polymorphisms in nuclear genes essential for mitochondrial biogenesis and function (PGC-1α TFAM) to late-onset Alzheimer's disease (LOAD) risk. Epistatic interaction analysis was conducted between the studied variables. Our results demonstrate that mtDNA haplogroups and subhaplogroups with putative role in partial uncoupling of oxidative phosphorylation are significantly associated with a decreased LOAD risk (OR <1). Conversely, mtDNA haplogroup H (p = 0.049) and HV cluster (p = 0.018) are significant LOAD risk factors, which was additionally confirmed by meta-analysis (OR = 1.22, OR = 1.25, respectively). Haplogroup K was demonstrated to exert a neutralizing effect on the high risk associated with APOE4+ status (p = 0.014). Further, two synergistic interactions between subhaplogroup H5 and APOE4 status (p = 0.009) and between TFAM rs1937 and APOE4 status (p < 0.001) were detected, influencing LOAD risk. No interaction pointing to a dual mitochondrial-nuclear genome variation effect on LOAD occurrence was identified.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21799244     DOI: 10.3233/JAD-2011-110710

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  24 in total

1.  Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.

Authors:  Yiwei Wang; Gerson Hernandez; Wendy J Mack; Lon S Schneider; Fei Yin; Roberta D Brinton
Journal:  Menopause       Date:  2020-01       Impact factor: 2.953

2.  A Genome-Wide Search for Bipolar Disorder Risk Loci Modified by Mitochondrial Genome Variation.

Authors:  Euijung Ryu; Malik Nassan; Gregory D Jenkins; Sebastian M Armasu; Ana Andreazza; Susan L McElroy; Marquis P Vawter; Mark A Frye; Joanna M Biernacka
Journal:  Mol Neuropsychiatry       Date:  2017-10-28

Review 3.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

Review 4.  Mitochondria, Cybrids, Aging, and Alzheimer's Disease.

Authors:  R H Swerdlow; S Koppel; I Weidling; C Hayley; Y Ji; H M Wilkins
Journal:  Prog Mol Biol Transl Sci       Date:  2017-02-01       Impact factor: 3.622

5.  Mitochondrial DNA Haplogroups and Susceptibility to Neuroblastoma.

Authors:  Xiao Chang; Marina Bakay; Yichuan Liu; Joseph Glessner; Komal S Rathi; Cuiping Hou; Huiqi Qu; Zalman Vaksman; Kenny Nguyen; Patrick M A Sleiman; Sharon J Diskin; John M Maris; Hakon Hakonarson
Journal:  J Natl Cancer Inst       Date:  2020-12-14       Impact factor: 13.506

6.  Late-onset Alzheimer's disease is associated with inherent changes in bioenergetics profiles.

Authors:  Kai-C Sonntag; Woo-In Ryu; Kristopher M Amirault; Ryan A Healy; Arthur J Siegel; Donna L McPhie; Brent Forester; Bruce M Cohen
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379

7.  ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease.

Authors:  Christopher W Medway; Samer Abdul-Hay; Tynickwa Mims; Li Ma; Gina Bisceglio; Fanggeng Zou; Shane Pankratz; Sigrid B Sando; Jan O Aasly; Maria Barcikowska; Joanna Siuda; Zbigniew K Wszolek; Owen A Ross; Minerva Carrasquillo; Dennis W Dickson; Neill Graff-Radford; Ronald C Petersen; Nilüfer Ertekin-Taner; Kevin Morgan; Guojun Bu; Steven G Younkin
Journal:  Mol Neurodegener       Date:  2014-03-10       Impact factor: 14.195

8.  Polymorphisms of CHAT but not TFAM or VR22 are Associated with Alzheimer Disease Risk.

Authors:  Lili Gao; Yan Zhang; Jinghua Deng; Wenbing Yu; Yunxia Yu
Journal:  Med Sci Monit       Date:  2016-06-07

9.  The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease.

Authors:  Katarzyna Gaweda-Walerych; Cezary Zekanowski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

Review 10.  Triad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex.

Authors:  Yiwei Wang; Roberta D Brinton
Journal:  Front Aging Neurosci       Date:  2016-10-04       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.